US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 4.4000
  • +0.0400+0.92%
Close Apr 24 16:00 ET
40.59MMarket Cap-575P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Single Segment2.24M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.24M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg